{'fraction_non_alphanumeric': 0.024447031431897557, 'fraction_numerical': 0.009313154831199068, 'mean_word_length': 5.37037037037037, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
[The best of 2001. Thrombosis].

Although it is impossible to recall all the new developments of the year 2001 regarding thrombosis, we have selected certain results: several, with although "negative" results, are highly interesting because they contradict preliminary studies which could have predicted therapeutic perspectives that would considerably alter the management of a common and serious illness. In this sense, they remind us that the large randomised studies (RCT) remain the necessary and indispensable tool for validating a large scale therapy: others, because they come within the logic of certain earlier results, and in this sense it is good for a clinician to see that a certain logic still exists in cardiology; others again, because they define a certainly real benefit, but whose limits of applicability could sometimes escape clinicians.